Medytox Overview
Company Headquarters: Seoul, South Korea
Founded: 2000
Workforce: ~280
Company Working: Medytox is a pharmaceutical company that manufactures, markets, and distributes medical aesthetics products across the globe. The company operates through business segments including, botulinum toxin products hyaluronic acid filler medical devices, and prescription drugs. Additionally, the company provides comfort dual, a medical device for tissue coagulation by using a high-frequency, and presently, Medytox exports its products to about 60 countries, including Brazil and Japan. company is planning to expand its business in the Americas and European countries through its subsidiaries Medytox US, Medybloom China, Medytox Taiwan, Medytox Hong Kong, MedyCeles, and MDT International (Japan). It has three manufacturing plants and one R&D center based in South Korea.
Strategy
Medytox focuses on developing innovative and unique biopharmaceutical products in order to maximize income and guarantee the greatest levels of customer satisfaction. The company is continuously involved in research and funding. Additionally, the company concentrates on offering high-quality products to increase its target audience and to capture maximum market share. Moreover, its long-term business strategy is to enter into strategic alliances as well as marketing and distribution agreements to expand its customer base.
